MA43465A1 - Compositions and methods for treating rheumatoid arthritis - Google Patents

Compositions and methods for treating rheumatoid arthritis

Info

Publication number
MA43465A1
MA43465A1 MA43465A MA43465A MA43465A1 MA 43465 A1 MA43465 A1 MA 43465A1 MA 43465 A MA43465 A MA 43465A MA 43465 A MA43465 A MA 43465A MA 43465 A1 MA43465 A1 MA 43465A1
Authority
MA
Morocco
Prior art keywords
rheumatoid arthritis
compositions
methods
treating rheumatoid
monotherapy
Prior art date
Application number
MA43465A
Other languages
French (fr)
Other versions
MA43465B2 (en
Inventor
Deborah Bauer
Alexander Boddy
Neil Graham
Yong Lin
Janie Parrino
Rahul Patel
Adelsberg Janet Van
Hoogstraten Hubert Van
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Priority claimed from PCT/US2017/021149 external-priority patent/WO2017155990A1/en
Publication of MA43465A1 publication Critical patent/MA43465A1/en
Publication of MA43465B2 publication Critical patent/MA43465B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne l'utilisation d'un anticorps du récepteur anti-il6 en monothérapie pour le traitement de la polyarthrite rhumatoïde et pour l'amélioration de la fonction physique et de la qualité de vie d'un sujet souffrant de polyarthrite rhumatoïde.The present invention relates to the use of an anti-il6 receptor antibody in monotherapy for the treatment of rheumatoid arthritis and for improving the physical function and quality of life of a subject suffering from rheumatoid arthritis.

MA43465A 2016-05-20 2017-03-07 Compositions and methods for treating rheumatoid arthritis MA43465B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16170664 2016-05-20
PCT/US2017/021149 WO2017155990A1 (en) 2016-03-07 2017-03-07 Compositions and methods for treating rheumatoid arthritis

Publications (2)

Publication Number Publication Date
MA43465A1 true MA43465A1 (en) 2019-03-29
MA43465B2 MA43465B2 (en) 2023-01-31

Family

ID=56101289

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43465A MA43465B2 (en) 2016-05-20 2017-03-07 Compositions and methods for treating rheumatoid arthritis

Country Status (1)

Country Link
MA (1) MA43465B2 (en)

Also Published As

Publication number Publication date
MA43465B2 (en) 2023-01-31

Similar Documents

Publication Publication Date Title
MA40755B1 (en) Compositions comprising bacterial strains
MA55434A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA41060A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
MA41010A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
MA49279A (en) ANTIBODY COMPOSITIONS OPTIMIZED FOR THE TREATMENT OF EYE DISORDERS
MA53937A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA35180B1 (en) Use of an anti-cd19 maytansinoide immunoconjugate antibody for the treatment of symptoms of B-cell malignancies
MA42471B1 (en) Compositions comprising bacterial strains
MA44334A (en) ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST
MA47313A (en) SUBCUTANEOUS FORMULATIONS OF HER2 ANTIBODIES
MA37946B1 (en) Use of an anti-gm-csf antibody for the treatment of rheumatoid arthritis
MA38632A1 (en) Anti-transferrin receptor antibody and methods of use
MA35660B1 (en) Inhibitors of the pak protein for the treatment of fragile x syndrome
MA50441A (en) NEW ASSOCIATION OF ACTIVE AGENTS FOR THE TREATMENT OF PROGRESSIVE INTERSTITIAL FIBROSAN PNEUMOPATHIES (PF-ILD)
MA47362A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE PSORIASIC RHEUMATISM
MX2018005589A (en) Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same.
BR112018067851A2 (en) compositions and methods for the treatment of rheumatoid arthritis
EA201992688A1 (en) MEANS, WAYS OF APPLICATION AND METHODS OF TREATMENT
MA38369A1 (en) Peptides and compositions for the treatment of a lesion of the joint
MA55490A (en) LIPOCALIN MUTEIN FOR THE TREATMENT OF ASTHMA
MA33842B1 (en) Use of 2,3-dihydroxypropyl dedkanot for the treatment of seborrheic dermatitis
MA46988A1 (en) Liquid formulation of anti-tnf alpha antibodies
MA43465A1 (en) Compositions and methods for treating rheumatoid arthritis
MA55218A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
MX2022004022A (en) Combinations of gaba-a receptor positive allosteric modulators and nmda antagonists, nmda negative allosteric modulators or nmda partial agonists.